Jean-Noël T.
- Country
- France
- Department
- Clinique Cardiologique et des Maladies Vasculaires
Research Overview
- A Long-term Safety Extension Study of Mavacamten (MYK-461) in Adults with Hypertrophic Cardiomyopathy Who Have Completed the MAVERICKHCM (MYK-461-006) or EXPLORER-HCM (MYK-461-005) Trials (MAVA-LTE)
- Long-term Safety and Tolerability Evaluation of Aficamten (CK-3773274) in Adults with Symptomatic Hypertrophic Cardiomyopathy: An Open-label Extension Study
- Evaluation of Mavacamten in Adults with Symptomatic Non-obstructive Hypertrophic Cardiomyopathy: A Randomized, Double-blind, Placebo-controlled Study
Data & Insights
Has run more than one trial at 33 of 109 partner sites.
Specializations
Cardiomyopathy Research
The investigator specializes in treating patients with hypertrophic cardiomyopathy (HCM), conducting extensive research into both obstructive and non-obstructive forms of the condition.
- Symptomatic HCM Management
- Non-obstructive HCM Treatment
- Obstructive HCM Therapies
Their work encompasses evaluation of cardiac structure and mass through advanced imaging techniques.
Novel Therapeutics
The investigator focuses on innovative treatments including aficamten and mavacamten for cardiac conditions, with particular attention to long-term safety and efficacy profiles.
- Cardiac Drug Development
- Long-term Safety Studies
- Treatment Tolerability Assessment
Their research emphasizes patient outcomes and treatment effectiveness in cardiovascular conditions.
Clinical Outcomes
The investigator evaluates patient-reported health status and physical capabilities, including exercise capacity and symptom improvement in cardiovascular patients.
- Exercise Capacity Assessment
- Symptom Management
- Physical Limitation Studies
Their research incorporates comprehensive evaluation of patient physical functioning and quality of life measures.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.